Noom

Excited to introduce Lose for Keeps — Noom's new campaign featuring Rebel Wilson, now launched across TV, streaming, social, and digital. The campaign is built around one idea: weight loss and healthy habits work better together. Our two new spots, “Mute Button” and “Training Wheels,” bring that idea to life in Rebel’s voice — with a special appearance from her three-year-old daughter, Royce. We’re also launching Rebel Wilson’s Microhabit Challenges in the Noom app: small, repeatable routines inspired by Rebel’s own #habits across sleep, nutrition, mood, and movement. The approach reflects what we see in our data. Members who pair GLP-1 treatment with Noom lose 37% more weight than on medication alone and achieve more than 3x better six-month weight maintenance. Medication can create an opening for change. Habits help make it last. Watch the spots: Mute Button: https://lnkd.in/g74zNSC5  Training Wheels: https://lnkd.in/g3s2tYgV Read more here: https://lnkd.in/gXe5UwKW

One sentence completely changed how I think about behavior change: "The curious paradox is that when I accept myself just as I am, then I can change." — Carl Rogers For years, I believed lasting change came from pushing harder. More discipline. More motivation. More willpower. Over the years I've realized that biology is only part of the equation. Psychology matters just as much. This idea came up during a recent conversation with Karen Mann MD, Medical Director at Noom, on The Optimized Woman Podcast. We talked about GLP-1s, behavior change, identity, and why sustainable health isn't just about better treatments. It's about understanding how biology and psychology work together. One idea from our conversation has stayed with me: Healthy habits become much easier when they come from self-respect instead of self-criticism. That doesn't mean lowering your standards. It means changing the place you're growing from. Instead of asking, "What's wrong with me?" Ask, "What's the next loving action I can take?" I'd love to hear your perspective. Has self-acceptance made it easier—or harder—for you to create lasting change? #Longevity #GLP1 #BehaviorChange

When it comes to improving population health, providing access to or coverage for GLP-1s isn't the same as investing in metabolic outcomes. Our Chief Commercial Officer, Cody Fair, wrote about the gap between the two and what a program built for durable outcomes looks like. Read the full piece 👇

The longevity conversation is often dominated by diagnostics, drugs, and optimization. But at Aspen Ideas: Health, one theme came through clearly: the missing layer isn’t what we can measure. It’s what we actually do. That was the focus of "The Longevity Mindset: Why Behavior — Not Biohacking — Will Define the Future of Health," featuring Dr. Jeffrey Egler, our Chief Medical Officer; Dr. David L. Katz, MD, MPH, founder of Diet ID and the True Health Initiative; Dr. Sarah Pressman, Professor of Psychology at UC Irvine; and moderated by Hilary Brueck of Business Insider. A few ideas that stayed with us: 𝗧𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗵𝗲𝗮𝗹𝘁𝗵 𝗶𝘀 𝗻𝗼𝘁 𝗷𝘂𝘀𝘁 𝗺𝗼𝗿𝗲 𝘁𝗼𝗼𝗹𝘀 – 𝗶𝘁’𝘀 𝗵𝗲𝗹𝗽𝗶𝗻𝗴 𝗽𝗲𝗼𝗽𝗹𝗲 𝘂𝘀𝗲 𝘁𝗵𝗼𝘀𝗲 𝘁𝗼𝗼𝗹𝘀 𝘁𝗼 𝗹𝗶𝘃𝗲 𝗯𝗲𝘁𝘁𝗲𝗿.  Most people already know the basics: move more, sleep well, eat nourishing foods, manage stress, stay connected. The hard part is turning that knowledge into routines that last. 𝗗𝗮𝘁𝗮 𝘀𝗵𝗼𝘂𝗹𝗱 𝗱𝗿𝗶𝘃𝗲 𝗮𝗰𝘁𝗶𝗼𝗻, 𝗻𝗼𝘁 𝗮𝗻𝘅𝗶𝗲𝘁𝘆. Diagnostics and wearables can be powerful, but only when they help people understand what to do next. Measurement matters most when it is relevant, interpretable, and actionable. 𝗚𝗟𝗣-𝟭𝘀 𝗰𝗮𝗻 𝗼𝗽𝗲𝗻 𝗮 𝘄𝗶𝗻𝗱𝗼𝘄, 𝗯𝘂𝘁 𝗵𝗮𝗯𝗶𝘁𝘀 𝗱𝗲𝘁𝗲𝗿𝗺𝗶𝗻𝗲 𝘄𝗵𝗮𝘁 𝗵𝗮𝗽𝗽𝗲𝗻𝘀 𝗻𝗲𝘅𝘁.  Medication can quiet food noise and create space to build new routines. But lasting change depends on the behaviors and support systems people build while that window is open. 𝗛𝗲𝗮𝗹𝘁𝗵𝘀𝗽𝗮𝗻 𝗶𝘀 𝗮𝗯𝗼𝘂𝘁 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗮𝘃𝗼𝗶𝗱𝗶𝗻𝗴 𝗱𝗶𝘀𝗲𝗮𝘀𝗲. Purpose, optimism, connection, joy, and agency are not “soft” factors. They are part of what helps people stay engaged in their health over time. A few lines that stuck with us: 💬 “Happiness should be a vital sign.” – Dr. Jeffrey Egler 💬 “Health is a currency you can spend on doing the things you want to do longer.” – Dr. David Katz 💬 “Longevity is the presence of the positive – purpose, optimism, joy – not just the absence of what’s wrong.” – Dr. Sarah Pressman You can watch the panel here: https://lnkd.in/g84bPrxZ Grateful to Hilary and our fellow panelists for a sharp, practical conversation — and to everyone who joined us in Aspen. #AspenIdeasHealth #Longevity #GLP1  #Healthspan

Two things are true about GLP-1s: they work, and most people eventually stop taking them. What happens next is the question that matters most. Today we’re answering it on two fronts. First, Noom’s GLP-1 Companion — the most behavior-science-backed companion in the category — is now free for anyone on a GLP-1 from any provider: personalized protein goals, AI food logging, Muscle Defense™ workouts to protect lean mass, side-effect support, and medication tracking. No subscription, no paywall. More here: https://lnkd.in/gtiTdPqw Second, we’re releasing new data on what happens after the medication ends. In early, observational analyses, Noom members regained roughly 3x less of their lost weight at 12 months than published post-discontinuation benchmarks (21.2% vs. 61.4%) — and the members who kept practicing Noom habits held onto the most. More here: https://lnkd.in/gYmFq86S The medication opens the door. Habits are what last. Now that support is free for everyone walking through it. Get the GLP-1 Companion in the Noom app → noom.com #GLP1 #BehaviorChange #DigitalHealth #Noom

Two things are true about GLP-1s: they work, and most people eventually stop taking them. What happens next is the question that matters most. Today we’re answering it on two fronts. First, Noom’s GLP-1 Companion — the most behavior-science-backed companion in the category — is now free for anyone on a GLP-1 from any provider: personalized protein goals, AI food logging, Muscle Defense™ workouts to protect lean mass, side-effect support, and medication tracking. No subscription, no paywall. More here: https://lnkd.in/gtiTdPqw Second, we’re releasing new data on what happens after the medication ends. In early, observational analyses, Noom members regained roughly 3x less of their lost weight at 12 months than published post-discontinuation benchmarks (21.2% vs. 61.4%) — and the members who kept practicing Noom habits held onto the most. More here: https://lnkd.in/gYmFq86S The medication opens the door. Habits are what last. Now that support is free for everyone walking through it. Get the GLP-1 Companion in the Noom app → noom.com #GLP1 #BehaviorChange #DigitalHealth #Noom

The longevity conversation is obsessed with scans, supplements, and optimization. But the missing layer is often the one that matters most: behavior. On June 24, Noom will take the stage at Aspen Ideas: Health for “The Longevity Mindset: Why Behavior — Not Biohacking — Will Define the Future of Health.” Our Chief Medical Officer, Dr. Jeffrey Egler, joins Dr. David L. Katz, MD, MPH, Dr. Sarah Pressman, and moderator Hilary Brueck of Business Insider for a conversation about how habits, identity, and daily action shape the future of healthy aging. Because the future of longevity won’t be defined only by what we measure. It will be defined by what we do — consistently, repeatedly, and over time. If you’ll be at Aspen Ideas: Health, we hope to see you there. Panel link: https://lnkd.in/g84bPrxZ #AspenIdeasHealth #Longevity #BehaviorChange #LifestyleMedicine #HealthyAging

The scale tells one story. Your biomarkers tell another. As Fierce Healthcare reports, we launched a new at-home biomarker test kit for U.S. members — giving people a simpler way to see what’s happening inside their bodies. That matters because many people are walking around with hidden health risks they can’t see: 1 in 3 American adults has prediabetes. 8 in 10 don’t know it. And early data from Noom’s Proactive Health program found that even among members with a healthy BMI, 70% had elevated LDL-C and 36% showed prediabetes markers. Most were completely unaware. Now Noom members can collect a small blood sample at home in under 10 minutes and get results across 17 key biomarkers delivered directly in the Noom app within a week. For members making lifestyle changes — especially those on GLP-1s — this means they can see how their habits and treatment are affecting their health beyond weight alone. That’s the Noom promise: Health you can see. Wellbeing you can feel. Read the full story: #Noom #BiomarkerTesting #PreventiveHealth #GLP1 #MetabolicHealth

What if the most important weight-loss results happen after the program ends? Today, we're sharing new research that challenges one of the most common assumptions in weight management: that people inevitably regain the weight once support goes away. Our largest-ever randomized controlled trial found the opposite. Published in Obesity Science & Practice, the peer-reviewed study followed 427 adults for 68 weeks — 16 weeks on Noom Weight, then a full year after the program ended. Here's what the data showed: • Noom members lost an average of 4.1% of their body weight by week 68, while the control group gained weight. • They were more than twice as likely to achieve clinically significant weight loss of 5% or more (41% vs. 19.5%) — a threshold linked to lower risk of type 2 diabetes, hypertension, and high cholesterol. • And they kept losing weight for a full year after the program ended — no app, no coaching, no active engagement. That last point matters most. In most weight-loss programs, people regain more than half of what they lost within a year. Our members didn't just hold their progress — they built on it. The reason is the foundation of everything we do: real, durable behavior change. When the skills become habits, the results last — with medication or without it. Read the full open-access study here: https://lnkd.in/evHZgnF2